Point72 Hong Kong’s Standard BioTools LAB Stock Holding History

Point72 Hong Kong’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-693	Closed	-$3K	–	2108
2021 Q4	$3K	Buy	+693	New	+$3.24K	﹤0.01%	1759
2021 Q1	–	Sell	-1,162	Closed	-$7K	–	2031
2020 Q4	$7K	Buy	+1,162	New	+$7.63K	﹤0.01%	1562
2020 Q3	–	Sell	-8,412	Closed	-$34K	–	1370
2020 Q2	$34K	Buy	+8,412	New	+$29.3K	﹤0.01%	806
2019 Q4	–	Sell	-766	Closed	-$4K	–	1317
2019 Q3	$4K	Buy	766 +664	+651%	+$5.23K	﹤0.01%	827
2019 Q2	$1K	Buy	+102	New	+$1.3K	﹤0.01%	1038
2019 Q1	–	Sell	-1,892	Closed	-$16K	–	1155
2018 Q4	$16K	Buy	+1,892	New	+$14.7K	0.01%	477

Other funds holding LAB

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Hong Kong's LAB Position: Q1 2022 in Review

Point72 Hong Kong sold out of Standard BioTools (LAB) in Q1 2022, closing a stake of 693 shares — an estimated $3K sold.

Point72 Hong Kong first reported a position in LAB in Q4 2018 and held it in 6 quarters. The position peaked at $34K in Q2 2020. 109 funds tracked by Wall St. Rank hold LAB as of Q1 2022.

Point72 Hong Kong reported no remaining Standard BioTools position as of Q1 2022 after selling out during the quarter.
Point72 Hong Kong sold 693 Standard BioTools shares in Q1 2022, an estimated $3K.
Point72 Hong Kong first reported a position in Standard BioTools in Q4 2018 and held it in 6 quarters.
Point72 Hong Kong's Standard BioTools position peaked at $34K in Q2 2020.
109 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.